Mammography/MQSA Regulatory Intelligence Report

The Complete Compliance, Accreditation, Quality, and Survey Readiness System for Breast Imaging Leaders

One Compliance Failure Can Shut Down an Entire Mammography Program

No imaging modality faces more regulatory scrutiny than Mammography.

Every mammography facility in the United States operates under the Mammography Quality Standards Act (MQSA), one of the most prescriptive and actively enforced regulatory frameworks in healthcare.

An expired certificate.

A missed physicist survey.

A personnel qualification lapse.

A missing dense breast notification.

Any one of these can trigger FDA enforcement action, accreditation loss, public reporting, civil penalties, and suspension of mammography services.

The RadVeritas Mammography / MQSA Regulatory Intelligence Report provides healthcare leaders with a comprehensive framework for maintaining certification, protecting accreditation, ensuring patient safety, and building a continuously survey-ready breast imaging program.

Why This Report Matters

Breast imaging is more than a regulatory obligation.

It is a life-saving service.

Every quality failure creates the potential for delayed cancer detection, patient harm, regulatory action, and reputational damage.

The organizations that consistently succeed are not those that prepare for inspections once a year.

They are the organizations that maintain readiness every day.

This report helps leaders identify vulnerabilities before they become findings.

What You'll Learn

MQSA Compliance and Certification

Understand the federal requirements governing:

• MQSA Certification

• FDA Inspections

• Accreditation Maintenance

• Personnel Qualifications

• Quality Control Programs

• Medical Outcomes Audits

• Patient Notification Requirements

Personnel Qualification Management

Strengthen oversight of:

• Interpreting Physicians

• Mammography Technologists

• Medical Physicists

• Continuing Education

• Continuing Experience Requirements

• Digital Breast Tomosynthesis (DBT) Training

Quality Control and Equipment Compliance

Develop effective systems for:

• Weekly Quality Control Testing

• Phantom Image Evaluation

• Compression Testing

• Artifact Monitoring

• Physicist Surveys

• Dose Monitoring

• Corrective Action Documentation

Dense Breast Notification Compliance

Navigate evolving federal and state requirements involving:

• Patient Lay Summary Letters

• Dense Breast Notifications

• Communication Timeliness

• Documentation Requirements

Medical Outcomes Audits

Build effective pathology correlation and performance improvement processes that support regulatory compliance and patient safety.

Key Areas Covered

✓ MQSA Certification Requirements

✓ FDA Inspection Readiness

✓ ACR Mammography Accreditation

✓ Digital Breast Tomosynthesis Compliance

✓ Personnel Qualification Tracking

✓ Medical Physicist Survey Requirements

✓ Quality Control Program Management

✓ Dense Breast Notification Compliance

✓ Medical Outcomes Audits

✓ Patient Communication Standards

✓ Leadership Accountability

✓ Survey Readiness and Risk Reduction

Powerful Tools Included

✔ MQSA Compliance Assessments

✔ Accreditation Readiness Checklists

✔ Personnel Qualification Tracking Systems

✔ Risk Assessment Matrices

✔ Quality Control Audit Tools

✔ Survey Readiness Dashboards

✔ Gap Analysis Frameworks

✔ Corrective Action Plans

✔ Executive Action Roadmaps

✔ Policy and Procedure Reviews

✔ Compliance Monitoring Tools

✔ Leadership Accountability Assessments

Designed For

• Breast Imaging Directors

• Mammography Managers

• Radiology Administrators

• Compliance Officers

• Accreditation Specialists

• Medical Physicists

• Interpreting Physicians

• Quality Leaders

• Patient Safety Officers

• Hospital Executives

• Healthcare Consultants

The Cost of Non-Compliance

Most imaging deficiencies result in corrective action plans.

MQSA deficiencies can result in loss of certification.

A single overlooked requirement can lead to:

• FDA Enforcement Action

• Accreditation Risk

• Public Disclosure of Deficiencies

• Service Interruption

• Revenue Loss

• Increased Liability Exposure

• Patient Safety Concerns

The consequences extend far beyond a survey finding.

Protect Your Certification. Protect Your Patients.

The RadVeritas Mammography / MQSA Regulatory Intelligence Report provides healthcare leaders with the intelligence, tools, and governance strategies needed to maintain certification, strengthen quality, improve patient safety, and sustain accreditation readiness.

Because in Mammography, compliance is not simply a regulatory requirement.

It is a commitment to every patient who trusts your organization to detect cancer when it matters most.

Protect Certification.

Strengthen Quality.

Save Lives.

Prepared By

Fred D. Elliott, Jr., CRA, MBA, BSHA, ARRT (CT), CRT

Founder and Principal Consultant

RadVeritas

Compliance • Quality • Governance

Turning MQSA Compliance Into Operational Excellence.

REGULATORY COMPLIANCE AND PATIENT SAFETY

CONTRAST MEDIA SAFETY AND MANAGEMENT

The Complete Patient Safety, Medication Management, and Regulatory Readiness System for Diagnostic Imaging Leaders

One Preventable Contrast Event Can Change Everything

A severe contrast reaction.

An undetected kidney impairment.

An extravasation injury.

A missed allergy history.

A delayed emergency response.

These events occur every day in healthcare organizations across the country, and many are entirely preventable.

Contrast media are among the most frequently administered medications in Diagnostic Imaging. Yet many organizations underestimate the regulatory, clinical, operational, and legal risks associated with their use.

The RadVeritas Contrast Media Safety and Management Regulatory Intelligence Report provides healthcare leaders with a comprehensive roadmap for protecting patients, strengthening compliance, reducing liability, and building a safer contrast administration program.

Built upon current CMS Conditions of Participation, The Joint Commission Medication Management standards, FDA requirements, and the American College of Radiology Manual on Contrast Media, this report transforms complex regulatory expectations into practical operational solutions.

Why This Report Matters

Every contrast administration carries risk.

Whether administering iodinated contrast for CT, gadolinium-based contrast for MRI, or contrast agents used in fluoroscopy and advanced imaging procedures, organizations are expected to maintain systems that protect patients before, during, and after administration.

Regulators, surveyors, accreditors, attorneys, and patients increasingly expect organizations to demonstrate:

• Effective patient screening

• Renal function assessment

• Allergy identification

• Emergency preparedness

• Adverse reaction management

• Personnel competency

• Documentation integrity

• Continuous quality oversight

This report helps leaders identify vulnerabilities before they become patient safety events, survey findings, or legal exposure.

What You'll Learn

Contrast Media Safety Governance

Build a structured framework for safe contrast administration across all imaging modalities.

Patient Screening and Risk Assessment

Strengthen processes for:

• Renal Function Assessment

• Contrast Allergy Screening

• Pregnancy Assessment

• Medication Review

• NSF Risk Identification

• High-Risk Patient Stratification

Emergency Preparedness

Develop effective systems for:

• Contrast Reaction Response

• Anaphylaxis Management

• Emergency Medication Availability

• Staff Competency Validation

• Simulation Training Programs

Regulatory Compliance

Navigate requirements from:

• CMS

• The Joint Commission

• ACR

• FDA

• State Licensing Agencies

Documentation and Audit Readiness

Improve compliance related to:

• Contrast Administration Records

• Adverse Event Reporting

• Extravasation Documentation

• Medication Management Standards

• Quality Improvement Monitoring

Key Areas Covered

✓ Contrast Media Safety Programs

✓ Iodinated Contrast Management

✓ Gadolinium-Based Contrast Agent Safety

✓ Nephrogenic Systemic Fibrosis Prevention

✓ Contrast-Induced Kidney Injury Risk Reduction

✓ Extravasation Prevention and Response

✓ Emergency Medication Readiness

✓ Personnel Training and Competency

✓ Medication Management Compliance

✓ Adverse Reaction Reporting

✓ Accreditation Readiness

✓ Leadership Accountability

Powerful Tools Included

✔ Contrast Safety Assessments

✔ Regulatory Risk Analysis Tools

✔ Survey Readiness Checklists

✔ Gap Analysis Frameworks

✔ Corrective Action Plans

✔ Executive Dashboards

✔ Emergency Response Readiness Evaluations

✔ Personnel Competency Tracking Systems

✔ Policy and Procedure Assessment Tools

✔ Risk Scoring Matrices

✔ Leadership Accountability Reviews

✔ Executive Action Roadmaps

Designed For

• Imaging Directors

• Radiology Administrators

• CT Leaders

• MRI Leaders

• Interventional Radiology Leaders

• Quality Improvement Professionals

• Patient Safety Officers

• Compliance Officers

• Accreditation Specialists

• Nursing Leaders

• Medical Directors

• Healthcare Consultants

The Hidden Risk Most Organizations Miss

Most contrast-related failures are not caused by a lack of policy.

They are caused by inconsistent execution.

A screening question that was never asked.

A kidney function result that was never reviewed.

An emergency medication that expired unnoticed.

A staff member who never received annual competency validation.

These seemingly small gaps can create significant patient safety and regulatory consequences.

The organizations that consistently perform well are those that build contrast safety into everyday operations, not just accreditation preparation.

Protect Patients. Reduce Risk. Lead With Confidence.

The RadVeritas Contrast Media Safety and Management Regulatory Intelligence Report provides the intelligence, tools, and governance framework needed to strengthen patient safety, improve regulatory compliance, reduce liability exposure, and support operational excellence.

Because contrast safety is more than a clinical responsibility.

It is a leadership responsibility.

Protect the Patient.

Protect the Organization.

Protect the Mission.

Prepared By

Fred D. Elliott, Jr., CRA, MBA, BSHA, ARRT (CT), CRT

Founder and Principal Consultant

RadVeritas

Compliance • Quality • Governance

Turning Contrast Media Safety Into Operational Excellence.